Reshape raised $20M in a Series A round of funding to scale its technology in the U.S. for automating lab experiments.
PRIVATEApr 09, 2024
Amount Raised
$20 Million
Round Type
Series A
CopenhagenBiotechnologySoftwareMachine Learning
Description
Reshape, a Danish startup, has raised $20 million in a Series A round of funding to scale its technology in the U.S. The company aims to automate lab experiments that involve visual inspections using a robotic imaging system replete with software and AI models.
Quick answer
Reshape raised $20 Million in a Series A round, dated April 9, 2024. Reshape is based in Copenhagen, Capital Region Of Denmark, Denmark.
How much did Reshape raise?
Reshape raised $20 Million in a Series A round on April 9, 2024.
What does Reshape do?
Reshape Biotech is building the next generation of lab automation robots.
Where is Reshape based and how big is it?
Reshape is based in Copenhagen, Capital Region Of Denmark, Denmark.
Source: Fundz verified event record.
Who to call at Reshape, and when
A new round usually means Reshape is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Reshape raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Reshape, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Reshape. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Reshape
Location
Copenhagen, Capital Region Of Denmark, Denmark
About
Reshape Biotech is building the next generation of lab automation robots. Our customers are biotech companies tackling the world’s biggest problems - be it alternative protein development or sustainable agriculture. Reshape Biotech is the scaling factor for these companies, as we let researchers collaborate globally on experiments and increase their throughput >500x.
The team is highly multi-disciplinary, employing everything from PhD’s in biology to hardware and software engineers. We work closely together, and you will be exposed to a truly vertical team.
We’re a fast growing startup with an incredibly ambitious team, dead-set on reinventing a 100 year old industry and becoming the standard infrastructure that the world of biotech relies on. Our customers already include global leaders in food, agriculture and biologicals.
We’re backed by top tier investors from Y Combinator, CEOs from the industry and some of the biggest names you can find. At Reshape Biotech, you have the potential to influence how biotech research is done in the next 100 years.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Reshape raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
CopenhagenBiotechnologySoftwareMachine Learning